// App-Quantinova.ai

6000 : Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.

Researchers

Presenter

  • Vijay Maruti Patil

Principal Investigators

  • Amit Joshi

  • Jaiprakash Agarwal

  • Sarbani Ghosh Laskar

  • Ashwini Budrukkar

  • Vedang Murthy

  • Sadhana Kannan

  • Atanu Bhattacharjee

  • Pankaj Chaturvedi

  • P. S. Pai

  • Devendra Chaukar

  • Anil K D'cruz

  • S Juvekar

  • Aparna Manjrekar

  • Vijayalakshmi Mathrudev

  • Kavita Prakash Nawale

  • Arti Bhelekar

  • Shripad Dinanath Banavali

  • Kumar Prabhash

Medical Centers

  • Tata Memorial Centre, Mumbai, India

  • Tata Memorial Hospital, Mumbai, India

  • Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Mumbai, India

  • TMH, Mumbai, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Nimotuzumab

  • Cisplatin

Outcome

  • Positive

Study Design

  • Randomized

  • Superiority

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved